News from AHA 2024: KRAKEN trial, Muvalaplin, Lp(a)

Stephen Nicholls at AHA

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

AHA exists 100 years: What can we possibly expect in the next century?
AHA exists 100 years: What can we possibly expect in the next century?
AHA 2024
AHA exists 100 years: What can we possibly expect in the next century?
- Keith Churchwell, MD
Bempedoic acid reduces adverse limb events in patients with PAD
Bempedoic acid reduces adverse limb events in patients with PAD
AHA 2024
Bempedoic acid reduces adverse limb events in patients with PAD
- Marc Bonaca, MD
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
AHA 2024
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
- Subodh Verma, MD, PhD
Audit and feedback strategy for pharmacists improves HF care
Audit and feedback strategy for pharmacists improves HF care
AHA 2024
Audit and feedback strategy for pharmacists improves HF care
- Alexander Sandhu, MD